患者均进行最佳矫正视力(BCVA)、裂隙灯显微镜、间接检眼镜及光相干断层扫描(OCT)检查确诊。
The IMH diagnosis was confirmed by best corrected visual acuity (BCVA), slit lamp microscope, indirect ophthalmoscope and optical coherence tomography (OCT).
治疗效果:所有患者达到预期最佳矫正视力,其中超过预期矫正视力2行以上者为51.1%(24眼),超过3行以上者为23.4%(11眼)。
Therapeutic effect: all the patients achieved expected best corrected visual acuity, 51.1% of them (24 eyes) were 2 lines better than expected, and 23.4% (11 eyes) were 3 lines better.
研究小组记录到:治疗后平均K值、SE和RMS误差降低,同时裸眼视力和最佳矫正视力提高了几行,并且两组患者角膜厚度增加,没有观察到角膜内皮细胞的丢失(表1)。
The team recorded a decrease in mean K, SE and RMS error, whilst lines were gained in UCVA and BSCVA, and pachymetry increased with no endothelial cell loss being observed in either group (Table 1).
术后第1、第3、第6个月由同一名医师询问患者术后总体评价、术后与术前最佳矫正视力时的视觉质量及视觉症状。
Obtain general evaluation, comparisons of pre - and post-operation visual quality and symptoms by the same clinician 1, 3, 6 months after ablative surgery.
术后第1、第3、第6个月由同一名医师询问患者术后总体评价、术后与术前最佳矫正视力时的视觉质量及视觉症状。
Obtain general evaluation, comparisons of pre - and post-operation visual quality and symptoms by the same clinician 1, 3, 6 months after ablative surgery.
应用推荐